Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial.

Cancer
Allyson J OceanDavid M Goldenberg

Abstract

It has been demonstrated that the humanized clivatuzumab tetraxetan (hPAM4) antibody targets pancreatic ductal carcinoma selectively. After a trial of radioimmunotherapy that determined the maximum tolerated dose of single-dose yttrium-90-labeled hPAM4 ((90) Y-hPAM4) and produced objective responses in patients with advanced pancreatic ductal carcinoma, the authors studied fractionated radioimmunotherapy combined with low-dose gemcitabine in this disease. Thirty-eight previously untreated patients (33 patients with stage IV disease and 5 patients with stage III disease) received gemcitabine 200 mg/m(2) weekly for 4 weeks with (90) Y-hPAM4 given weekly in Weeks 2, 3, and 4 (cycle 1), and the same cycle was repeated in 13 patients (cycles 2-4). In the first part of the study, 19 patients received escalating weekly (90) Y doses of 6.5 mCi/m(2) , 9.0 mCi/m(2) , 12.0 mCi/m(2) , and 15.0 mCi/m(2) . In the second portion, 19 additional patients received weekly doses of 9.0 mCi/m(2) or 12.0 mCi/m(2) . Grade 3/4 thrombocytopenia or neutropenia (according to version 3.0 of the National Cancer Institute's Common Terminology Criteria for Adverse Events) developed in 28 of 38 patients after cycle 1 and in all retreated patients; no grade >3...Continue Reading

References

Jan 1, 1994·International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement·R SteinM J Mattes
May 16, 1997·International Journal of Cancer. Journal International Du Cancer·D V GoldR Blumenthal
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Mar 20, 2001·Critical Reviews in Oncology/hematology·C M Richman, S J DeNardo
Jan 5, 2002·International Journal of Cancer. Journal International Du Cancer·Thomas M CardilloDavid V Gold
Mar 3, 2004·International Journal of Cancer. Journal International Du Cancer·David V GoldThomas M Cardillo
Jan 6, 2005·The Oncologist·Bea PauwelsJan B Vermorken
Apr 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm J MooreUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Dec 21, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David V GoldRalph H Hruban
Nov 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Meredith A MorganTheodore S Lawrence
Dec 19, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L H SchwartzE A Eisenhauer
Apr 30, 2010·The New England Journal of Medicine·Manuel Hidalgo
Jul 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Franck MorschhauserDavid M Goldenberg
Sep 3, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·David V GoldDavid M Goldenberg
Mar 15, 2011·Immunotherapy·Robert M Sharkey, David M Goldenberg
Apr 30, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Seza A GulecDavid M Goldenberg
May 13, 2011·The New England Journal of Medicine·Thierry ConroyUNKNOWN PRODIGE Intergroup
Oct 5, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel D Von HoffManuel Hidalgo

❮ Previous
Next ❯

Citations

Jul 23, 2013·Clinical Oncology : a Journal of the Royal College of Radiologists·M R JacksonK A Vallis
Dec 15, 2012·Critical Reviews in Oncogenesis·Clifford WhatcottDaniel D Von Hoff
Mar 1, 2014·British Journal of Cancer·M K NygrenS-K Leivonen
May 4, 2013·Immunotherapy·Isabelle Navarro-TeulonJean-Pierre Pouget
Apr 17, 2014·Journal of Carcinogenesis·Ravi ChhatralaRenuka Iyer
Jun 24, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·George Sgouros, David M Goldenberg
Jan 6, 2016·International Journal of Molecular Sciences·Sergey V GudkovAndrei V Zvyagin
Feb 14, 2015·International Journal of Molecular Sciences·Françoise Kraeber-BodéréJacques Barbet
Oct 11, 2015·Expert Opinion on Biological Therapy·Gareth RivallandPaul Mitchell
Jun 9, 2016·Nuclear Medicine and Molecular Imaging·Jin Su Kim
Jul 19, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Vincent J PicozziDaniel D Von Hoff
Aug 1, 2015·Cancer Gene Therapy·M ShahE Dadachova
May 1, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Marie SahlinDaniel Ansari
Apr 29, 2015·Molecular Immunology·J M RedmanL M Weiner
May 23, 2015·Nature Reviews. Cancer·Steven M LarsonOliver W Press
May 4, 2015·Journal of Hematology & Oncology·Gaurav Goel, Weijing Sun
Mar 8, 2014·Oncoimmunology·Erika VacchelliLorenzo Galluzzi
Dec 3, 2014·Seminars in Oncology·Françoise Kraeber-BodéréMichel Chérel
Jan 17, 2015·Frontiers in Medicine·Floor C J van de WateringOtto C Boerman
Feb 24, 2015·Frontiers in Medicine·Françoise Kraeber-Bodéré, Jacques Barbet
Mar 4, 2017·Expert Opinion on Emerging Drugs·Kalliopi AndrikouStefano Cascinu
Mar 11, 2015·Therapeutic Advances in Medical Oncology·Andrea TeagueAndrea Wang-Gillam
Feb 5, 2016·Journal of Cancer Research and Clinical Oncology·Elias KotteasKonstantinos Syrigos
Jul 27, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Federica ZorattoS Tomao
Nov 8, 2017·Human Vaccines & Immunotherapeutics·Inga HochnadelTetyana Yevsa
Aug 27, 2014·Expert Review of Anticancer Therapy·Ruth A BryanEkaterina Dadachova
Sep 16, 2015·Oncotarget·Akintunde AkinleyeDelong Liu
Jan 19, 2018·Oncology Letters·Cornelia NitipirCarolina Negrei
Nov 14, 2019·International Journal of Molecular Sciences·Javeria ZaheerSang Moo Lim
Sep 25, 2019·International Journal of Molecular Sciences·Javeria ZaheerJin Su Kim
Aug 21, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Vivek SubbiahGregory Ravizzini
Oct 31, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Françoise Kraeber-BodéréJean-François Chatal
Feb 22, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Rebecca A HerbertsonAndrew M Scott
Jul 3, 2021·International Journal of Molecular Sciences·Christopher MontemagnoGilles Pagès
Nov 1, 2018·Chemical Reviews·Thomas I Kostelnik, Chris Orvig

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Seza A GulecDavid M Goldenberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Tim MeyerRichard H Begent
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Oliver Sartor
© 2021 Meta ULC. All rights reserved